Page 1 of Clinical Trials for Simulect, 96 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant
Last Updated: May 24, 2011
Condition(s): Reduction in Sequelae Related to Calcineurin Inhibitors; Chimeric Antibody Sensitization; Allograft Rejection
2
Not yet recruiting
Pharmacodynamics, Efficacy, Safety of Basiliximab 40 or 80 mg Combined With CsA or Everolimus, in Low Risk de Novo Renal Transplant Recipients
Last Updated: March 1, 2012
Condition(s): Renal Transplantation
3
Recruiting
Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)
Last Updated: May 8, 2012
Condition(s): Renal Transplantation
4
Completed
Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids
Last Updated: May 7, 2012
Condition(s): Kidney Transplantation; Adverse Effects
5
Completed
Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids
Last Updated: August 17, 2011
Condition(s): Liver Transplantation; Infection
6
Completed
Basiliximab in Moderate to Severe Ulcerative Colitis
Last Updated: December 17, 2008
Condition(s): Ulcerative Colitis
7
Not yet recruiting
Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma
Last Updated: November 18, 2011
Condition(s): Recurrent Adult Hodgkin Lymphoma
8
Terminated
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
Last Updated: August 17, 2010
Condition(s): Non-infectious Uveitis
9
Not yet recruiting
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Last Updated: December 2, 2011
Condition(s): Graft Versus Host Disease; Steroid Refractory GVHD; Acute GVH Disease
10
Terminated
Basiliximab Maintenance in Ulcerative Colitis
Last Updated: February 2, 2010
Condition(s): Ulcerative Colitis
11
Completed
Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients
Last Updated: December 12, 2006
Condition(s): Corneal Transplantation
12
Completed
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
Last Updated: July 31, 2009
Condition(s): Cadaveric Donor Renal Transplantation; Acute Renal Allograft Rejection; Induction Therapy
13
Recruiting
Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
Last Updated: June 30, 2011
Condition(s): Diabetes; Immunosuppression
14
Completed
Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients
Last Updated: August 24, 2010
Condition(s): Pediatric Kidney Transplantation
15
Completed
Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients
Last Updated: March 28, 2011
Condition(s): Organ Transplantation, Renal Transplantation
16
Recruiting
Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance
Last Updated: June 9, 2011
Condition(s): Kidney Transplant
17
Active, not recruiting
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
Last Updated: May 15, 2012
Condition(s): Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplasia; Non-Hodgkin's Lymphoma; Hodgkin's Disease; Multiple Myeloma; Myelofibrosis; Anemia, Aplastic; Hemoglobinuria, Paroxysmal
18
Completed
Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant
Last Updated: May 1, 2009
Condition(s): Lung Transplant
19
Recruiting
Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation
Last Updated: September 14, 2011
Condition(s): Liver Transplantation; Chronic Renal Insufficiency
20
Completed
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
Last Updated: August 10, 2011
Condition(s): Kidney Transplantation

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Simulect

Page 1 of Clinical Trials for Simulect, 96 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About